|Articles|October 1, 1999

The Appropriate Use of Antibiotic Therapy
Volume 5
Issue 15 Suppl

Drug Resistance and the Treatment of Upper Respiratory Infections

Author(s)William R. Bishai, MD, PhD, Richard E. Chaisson, MD

Download PDF: Drug Resistance and the Treatment of Upper Respiratory Infections

Articles in this issue

almost 27 years ago

Article

Participating Faculty

almost 27 years ago

Article

Introduction

almost 27 years ago

Article

Intramuscular Antibiotics in the Treatment of Pediatric Upper Respiratory Tract Infection

almost 27 years ago

Article

Assessing the Risk of Adverse Reactions to Intramuscular Benzathine Penicillin G

almost 27 years ago

Article

Diagnosis and Management of Group A Streptococcal Pharyngitis: A Practice Guideline

almost 27 years ago

Article

CME Quiz

almost 27 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Drug Resistance and the Treatment of Upper Respiratory Infections

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Novel Iberdomide Regimen in RRMM

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk

IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds

Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key